Dr. Andrew James Zganjar, MD

Dr. Zganjar practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Zganjar's NPI, 1235524018, was assigned on March 30, 2015. Dr. Zganjar graduated from Medical College Of Wisconsin in 2015. Dr. Zganjar holds Florida license ME155049.

Dr. Zganjar's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Zganjar's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zganjar practices. Vendor and product names are available with a free account.

Urology is Dr. Zganjar's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Zganjar is board certified in urology by the American Board of Urology. Dmand AI has Dr. Zganjar's licenses on file in 6 states: Florida, Georgia, Minnesota, Wisconsin, Kansas and Missouri.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease and prostate surgery among the conditions Dr. Zganjar treats.

CMS data shows 15,490 Medicare services from Dr. Zganjar across 26 procedure codes in 2024, for 516 Medicare patients. Medicare paid $221,449 for them.

CMS counts 516 Medicare patients who saw Dr. Zganjar in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zganjar's median patient age at 76, with 27% women.

In 2024, Dr. Zganjar wrote 31 Medicare Part D claims for 21 patients. 84% of them were for generic drugs. CMS names the drug for 29 of them, across 1 drug with 11 or more claims each, at $485 in total drug cost. In 2021, CMS named 65 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Zganjar for performance year 2024, reported as part of a group. Dr. Zganjar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zganjar as offering telehealth. CMS counts 17 procedures of prostate resection by Dr. Zganjar, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 26 papers to Dr. Zganjar, published from 2018 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Cystectomy, Kidney Neoplasms and Urinary Bladder Neoplasms. Dr. Zganjar has published most often in Urol Oncol. Dr. Zganjar's most frequent co-authors are Stephen Anthony Boorjian, MD, Timothy David Lyon, MD and Aaron Mark Potretzke, MD.

CMS Open Payments shows 24 general payments to Dr. Zganjar from 16 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Coloplast Corp paid the most, $502.

Dmand AI lists 6 awards for Dr. Zganjar, most recently Teacher of the Year in 2025. Dr. Zganjar serves on Comprehensive Research Team.

Dr. Zganjar graduated from Medical College Of Wisconsin in 2015. Dr. Zganjar is a member of AOA and AUA.

Dr. Zganjar is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and Aetna. POS plans come from the most carriers, 6. Check the plan with the practice before a visit.